Dataset Information

Evaluation of data integration strategies based on kernel method of clinical and microarray data.

ABSTRACT: The cancer classification problem is one of the most challenging problems in bioinformatics. The data provided by Netherland Cancer Institute consists of 295 breast cancer patient; 101 patients are with distant metastases and 194 patients are without distant metastases. Combination of features sets based on kernel method to classify the patient who are with or without distant metastases will be investigated. The single data set will be compared with three data integration strategies and also weighted data integration strategies based on kernel method. Least Square Support Vector Machine (LS-SVM) is chosen as the classifier because it can handle very high dimensional features, for instance, microarray data. The experiment result shows that the performance of weighted late integration and the using of only microarray data are almost similar. The data integration strategy is not always better than using single data set in this case. The performance of classification absolutely depends on the features that are used to represent the object.

SUBMITTER: Noviyanto A

PROVIDER: S-EPMC3283887 | biostudies-other | 2012

REPOSITORIES: biostudies-other

ACCESS DATA

Publications

Evaluation of data integration strategies based on kernel method of clinical and microarray data.

Noviyanto Ary A Wasito Ito I

Bioinformation 20120203 3

The cancer classification problem is one of the most challenging problems in bioinformatics. The data provided by Netherland Cancer Institute consists of 295 breast cancer patient; 101 patients are with distant metastases and 194 patients are without distant metastases. Combination of features sets based on kernel method to classify the patient who are with or without distant metastases will be investigated. The single data set will be compared with three data integration strategies and also wei ...[more]

PMID: 22368387

Similar Datasets

Project description:BackgroundAlthough microarray technology allows the investigation of the transcriptomic make-up of a tumor in one experiment, the transcriptome does not completely reflect the underlying biology due to alternative splicing, post-translational modifications, as well as the influence of pathological conditions (for example, cancer) on transcription and translation. This increases the importance of fusing more than one source of genome-wide data, such as the genome, transcriptome, proteome, and epigenome. The current increase in the amount of available omics data emphasizes the need for a methodological integration framework.MethodsWe propose a kernel-based approach for clinical decision support in which many genome-wide data sources are combined. Integration occurs within the patient domain at the level of kernel matrices before building the classifier. As supervised classification algorithm, a weighted least squares support vector machine is used. We apply this framework to two cancer cases, namely, a rectal cancer data set containing microarray and proteomics data and a prostate cancer data set containing microarray and genomics data. For both cases, multiple outcomes are predicted.ResultsFor the rectal cancer outcomes, the highest leave-one-out (LOO) areas under the receiver operating characteristic curves (AUC) were obtained when combining microarray and proteomics data gathered during therapy and ranged from 0.927 to 0.987. For prostate cancer, all four outcomes had a better LOO AUC when combining microarray and genomics data, ranging from 0.786 for recurrence to 0.987 for metastasis.ConclusionsFor both cancer sites the prediction of all outcomes improved when more than one genome-wide data set was considered. This suggests that integrating multiple genome-wide data sources increases the predictive performance of clinical decision support models. This emphasizes the need for comprehensive multi-modal data. We acknowledge that, in a first phase, this will substantially increase costs; however, this is a necessary investment to ultimately obtain cost-efficient models usable in patient tailored therapy.

Dataset Information

Evaluation of data integration strategies based on kernel method of clinical and microarray data.

Publications

Evaluation of data integration strategies based on kernel method of clinical and microarray data.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure